Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EEF2
Introduction
Eukaryotic elongation factor 2 is a protein that in humans is encoded by the EEF2 gene.[1][2][3]
This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the ribosome. This protein is completely inactivated by EF-2 kinase phosphorylation.[3]
EEF2 contains a post transcriptionally modified histadine diphthamide. It is the target of diphtheria toxin (from Corynebacterium diphtheriae), and exotoxin A (from Pseudomonas aeruginosa).[4] The inactivation of EF-2 by toxins inhibits protein production in the host, causing symptoms due to loss of function in affected cells.
References
References
- ↑ Rapp G, Klaudiny J, Hagendorff G, Luck MR, Scheit KH (Mar 1990). “Complete sequence of the coding region of human elongation factor 2 (EF-2) by enzymatic amplification of cDNA from human ovarian granulosa cells”. Biol Chem Hoppe-Seyler. 370 (10): 1071–5. doi:10.1515/bchm3.1989.370.2.1071. PMID 2610926.
- ↑ Kaneda Y, Yoshida MC, Kohno K, Uchida T, Okada Y (Jul 1984). “Chromosomal assignment of the gene for human elongation factor 2”. Proc Natl Acad Sci U S A. 81 (10): 3158–62. doi:10.1073/pnas.81.10.3158. PMC 345240. PMID 6427766.
- ↑ 3.0 3.1 “Entrez Gene: EEF2 eukaryotic translation elongation factor 2”.
- ↑ Jørgensen R, Merrill AR, Andersen GR (February 2006). “The life and death of translation elongation factor 2”. Biochem. Soc. Trans. 34 (Pt 1): 1–6. doi:10.1042/BST20060001. PMID 16246167.
Further reading
Further reading
- Hanes J, Freudenstein J, Rapp G, Scheit KH (1992). “Construction of a plasmid containing the complete coding region of human elongation factor 2”. Biol. Chem. Hoppe-Seyler. 373 (4): 201–4. doi:10.1515/bchm3.1992.373.1.201. PMID 1596361.
- NygÃ¥rd O, Nilsson L (1990). “Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes”. J. Biol. Chem. 265 (11): 6030–4. PMID 2318846.
- Rapp G, Mucha J, Einspanier R, et al. (1988). “Cloning and sequence analysis of a cDNA from human ovarian granulosa cells encoding the C-terminal part of human elongation factor 2”. Biol. Chem. Hoppe-Seyler. 369 (4): 247–50. doi:10.1515/bchm3.1988.369.1.247. PMID 2840927.
- Kaneda Y, Hayes H, Uchida T, et al. (1987). “Regional assignment of five genes on human chromosome 19”. Chromosoma. 95 (1): 8–12. doi:10.1007/BF00293835. PMID 3034518.
- Nairn AC, Palfrey HC (1988). “Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2”. J. Biol. Chem. 262 (36): 17299–303. PMID 3693353.
- Shestakova EA, Motuz LP, Minin AA, Gavrilova LP (1993). “Study of localization of the protein-synthesizing machinery along actin filament bundles”. Cell Biol. Int. 17 (4): 409–16. doi:10.1006/cbir.1993.1079. PMID 8318952.
- Redpath NT, Price NT, Severinov KV, Proud CG (1993). “Regulation of elongation factor-2 by multisite phosphorylation”. Eur. J. Biochem. 213 (2): 689–99. doi:10.1111/j.1432-1033.1993.tb17809.x. PMID 8386634.
- Knebel A, Haydon CE, Morrice N, Cohen P (2002). “Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways”. Biochem. J. 367 (Pt 2): 525–32. doi:10.1042/BJ20020916. PMC 1222910. PMID 12171600.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Yin X, Fontoura BM, Morimoto T, Carroll RB (2003). “Cytoplasmic complex of p53 and eEF2”. J. Cell. Physiol. 196 (3): 474–82. doi:10.1002/jcp.10329. PMID 12891704.
- Ryazanova LV, Dorovkov MV, Ansari A, Ryazanov AG (2004). “Characterization of the protein kinase activity of TRPM7/ChaK1, a protein kinase fused to the transient receptor potential ion channel”. J. Biol. Chem. 279 (5): 3708–16. doi:10.1074/jbc.M308820200. PMID 14594813.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Elo MA, Karjalainen HM, Sironen RK, et al. (2005). “High hydrostatic pressure inhibits the biosynthesis of eukaryotic elongation factor-2”. J. Cell. Biochem. 94 (3): 497–507. doi:10.1002/jcb.20333. PMID 15534876.
- Andersen JS, Lam YW, Leung AK, et al. (2005). “Nucleolar proteome dynamics”. Nature. 433 (7021): 77–83. doi:10.1038/nature03207. PMID 15635413.
- Shibatani T, David LL, McCormack AL, et al. (2005). “Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits”. Biochemistry. 44 (16): 5982–92. doi:10.1021/bi047328f. PMID 15835887.
- Ahmed M, Forsberg J, Bergsten P (2005). “Protein profiling of human pancreatic islets by two-dimensional gel electrophoresis and mass spectrometry”. J. Proteome Res. 4 (3): 931–40. doi:10.1021/pr050024a. PMID 15952740.
- Gevaert K, Staes A, Van Damme J, et al. (2006). “Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC”. Proteomics. 5 (14): 3589–99. doi:10.1002/pmic.200401217. PMID 16097034.
External links
External links
- Peptide+Elongation+Factor+2 at the US National Library of Medicine Medical Subject Headings (MeSH)